156 related articles for article (PubMed ID: 24376974)
1. Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review.
Lopez JL; Pérez C; Marquez C; Cabrera P; Perez JM; Ramirez GL; Ordoñez R; Praena-Fernandez JM; Ortiz MJ
Rep Pract Oncol Radiother; 2011 May; 16(5):163-9. PubMed ID: 24376974
[TBL] [Abstract][Full Text] [Related]
2. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
Kushner BH; Meyers PA
J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286
[TBL] [Abstract][Full Text] [Related]
4. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
[TBL] [Abstract][Full Text] [Related]
5. Role of radiation therapy in the multidisciplinary management of Ewing's Sarcoma of bone in pediatric patients: An effective treatment for local control.
Lopez JL; Cabrera P; Ordoñez R; Marquez C; Ramirez GL; Praena-Fernandez JM; Ortiz MJ
Rep Pract Oncol Radiother; 2011; 16(3):103-9. PubMed ID: 24376965
[TBL] [Abstract][Full Text] [Related]
6. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
7. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
Meyers PA; Krailo MD; Ladanyi M; Chan KW; Sailer SL; Dickman PS; Baker DL; Davis JH; Gerbing RB; Grovas A; Herzog CE; Lindsley KL; Liu-Mares W; Nachman JB; Sieger L; Wadman J; Gorlick RG
J Clin Oncol; 2001 Jun; 19(11):2812-20. PubMed ID: 11387352
[TBL] [Abstract][Full Text] [Related]
8. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
Wexler LH; DeLaney TF; Tsokos M; Avila N; Steinberg SM; Weaver-McClure L; Jacobson J; Jarosinski P; Hijazi YM; Balis FM; Horowitz ME
Cancer; 1996 Aug; 78(4):901-11. PubMed ID: 8756388
[TBL] [Abstract][Full Text] [Related]
10. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
[TBL] [Abstract][Full Text] [Related]
11. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
12. Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
Luksch R; Tienghi A; Hall KS; Fagioli F; Picci P; Barbieri E; Gandola L; Eriksson M; Ruggieri P; Daolio P; Lindholm P; Prete A; Bisogno G; Tamburini A; Grignani G; Abate ME; Podda M; Smeland S; Ferrari S
Ann Oncol; 2012 Nov; 23(11):2970-2976. PubMed ID: 22771824
[TBL] [Abstract][Full Text] [Related]
13. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.
Burdach S; Meyer-Bahlburg A; Laws HJ; Haase R; van Kaik B; Metzner B; Wawer A; Finke R; Göbel U; Haerting J; Pape H; Gadner H; Dunst J; Juergens H
J Clin Oncol; 2003 Aug; 21(16):3072-8. PubMed ID: 12915596
[TBL] [Abstract][Full Text] [Related]
14. Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands.
Smorenburg CH; van Groeningen CJ; Meijer OW; Visser M; Boven E
Neth J Med; 2007 Apr; 65(4):132-6. PubMed ID: 17452761
[TBL] [Abstract][Full Text] [Related]
15. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F
J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881
[TBL] [Abstract][Full Text] [Related]
16. Outcome of multimodality treatment of Ewing's sarcoma of the extremities.
Tiwari A; Gupta H; Jain S; Kapoor G
Indian J Orthop; 2010 Oct; 44(4):378-83. PubMed ID: 20924477
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors.
Tanaka K; Matsunobu T; Sakamoto A; Matsuda S; Iwamoto Y
J Orthop Sci; 2002; 7(4):477-82. PubMed ID: 12181663
[TBL] [Abstract][Full Text] [Related]
18. Extraskeletal Ewing's sarcoma.
Ahmad R; Mayol BR; Davis M; Rougraff BT
Cancer; 1999 Feb; 85(3):725-31. PubMed ID: 10091746
[TBL] [Abstract][Full Text] [Related]
19. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
[TBL] [Abstract][Full Text] [Related]
20. Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment.
Argon A; Basaran M; Yaman F; Dizdar Y; Sakar B; Camlica H; Bavbek SE; Ozger H; Darendeliler E; Onat H
Jpn J Clin Oncol; 2004 Nov; 34(11):667-72. PubMed ID: 15613556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
